HomeWistar TodayWistar WireMelanomaWistar Wire: Melanoma
Wistar Today

Wistar Wire: Melanoma

Tags

The Top 10 Thing You Need to Know about Melanoma Awareness Month
May 2, 2013
glester
May is Melanoma Awareness Month. Melanoma is an aggressive form of skin cancer and worldwide rates of melanoma are on the rise. Click through to read 10 things you ought to know about melanoma!
Read Full Post
Melanoma
Cancer Biology Student Awarded Melanoma Research Grant
April 3, 2013
glester
Amanpreet Kaur, a student in the Cancer Biology Ph.D. program, a joint venture between Wistar and University of the Sciences, was recently awarded at $10,000 grant by the Joanna M. Nicolay Melanoma Foundation. Kaur, who studies in the laboratory of her mentor, Wistar Assistant Professor Ashani Weeraratna, Ph.D., will use the money to further her work on protein receptors that play an important role in melanoma progression and therapy resistance.
Read Full Post
Events, Funding, Melanoma
Expert Opinion: Melanoma Risk Still High in the Winter.
January 23, 2013
wistar
It may not seem like it, but the winter sun still packs a punch, especially when it comes to melanoma, an aggressive form of skin cancer. “There’s a saying we like to use: ‘Melanoma doesn’t hibernate.’ So just because it’s cold outside does not mean sun exposure can’t be dangerous,” said Ashani Weeraratna, Ph.D.
Read Full Post
Cancer, Melanoma
The Paradox of BRAF Inhibitors in Melanoma Care
January 19, 2012
wistar
A BRAF inhibitor known as vemurafenib (Zelboraf) has been touted as a breakthrough melanoma treatment. But for some patients, the price of success is a mutation that leads to the development of secondary skin cancers called squamous cell carcinomas. In an editorial in The New England Journal of Medicine, Wistar researcher Ashani Weeraratna, Ph.D., discusses the success of a new combination treatment.
Read Full Post
Cancer, Genes, Melanoma